← All patents

US11427816B2

Cancer treatment through RLIP76 partial depletion

University of Texas System

Abstract

Partial depletion of RLIP76 in p53 deficient living subject has shown many health benefits. In one embodiment, partical Rlip depletion is used to prevent or treat cancer in p53 deficient living subjects. In another embodiment, partial Rlip depletion is used for reversion of DNA-methylation …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Sanjay Awasthi
Priority date
August 23, 2017
Filing date
August 23, 2017
Grant date
August 30, 2022
Publication date
August 30, 2022
Language
en
Metadata fetched
August 29, 2026 00:29